Stocks and Investing
Stocks and Investing
Mon, April 16, 2018
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Fri, April 13, 2018
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Thu, April 12, 2018
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Madhu Kumar Downgraded (APLS) to Hold on, Apr 12th, 2018
Madhu Kumar of B. Riley Securities, Downgraded "Apellis Pharmaceuticals, Inc." (APLS) to Hold on, Apr 12th, 2018.
Madhu has made no other calls on APLS in the last 4 months.
There is 1 other peer that has a rating on APLS. Out of the 1 peers that are also analyzing APLS, 0 agree with Madhu's Rating of Hold.
This is the rating of the analyst that currently disagrees with Madhu
- Anupam Rama of "JP Morgan" Maintained at Buy with Increased Target to $35 on, Friday, March 23rd, 2018
Contributing Sources